ingly, altered autonomic outflow presents as alterations inbowel habits, altered perceptual responses manifest as viscero-and somatosensory symptoms, and constitutional functions.We recently reported that patients with ``hard/lumpy'' stools,a criterion for constipation, had lower rectal thresholds tomechanical distension than those with normal stools; likewise,patients with the diarrhea-supporting criterion ``loose/watery''stools had higher thresholds than those with normal stools [15].We also found that in IBS patients without fibromyalgia, thosein the IBS-C group, as compared to the IBS-D group, showed agreater prevalence of a wide range of symptoms related to theupper and lower abdomen and to musculoskeletal andconstitutional functions such as early satiety, fullness, upperabdominal bloating, higher severity ratings for lower gastro-intestinal bloating, neck/shoulders and back/hip pain, sleepimpairment, loss of appetite and decreased sexual function [27].Effect of foodMost patients with IBS report that food excacerbates theirsymptoms. Food intake could result in symptoms via excessiveactivation of mechanoreceptors due to increased intraluminalvolumes or increased motor activity, such as a prolongedgastrocolonic response, increased gas production resulting inintestinal distension, interaction of food components withchemoreceptors in the mucosa, and triggering of true allergicresponses [5]. We have shown that gastrocolonic response inIBS patients induced an increase in rectal tone and a reductionin rectal compliance in IBS-D patients as well as a decrease inrectal perception threshold in this subgroup [28]. These findingscould explain the postprandial urgency reported by IBS-Dpatients. Furthermore, a variety of food components, includingglucose, amino acids and fatty acids, interact via the release ofchemical substances such as cholecystokinin. Cholecystokinin-mediated activation of vagal chemoreceptors plays a role in theregulation of gastric and intestinal motility, and activation ofmechanoreceptive vagal afferents may play a role in modulationof visceral perception [5].Capsaicin, the pungent ingredient of peppers, has been wellcharacterized as a selective stimulant of unmyelinated C-fibersensory afferent neurons, such as the peripheral terminals ofspinal and vagal afferents. Approximately 80% of C-fiberafferent neurons are polymodal ``silent'' nociceptors activatedby noxious thermal, mechanical or chemical stimuli. Capsaicinstimulation results in many physiological effects such as bloodflow alteration, smooth muscle contractility, and the release ofmany neuropeptides including substance P, known to mediatepain [5]. We have shown that 1 g of guajillo chili pepper(0.112% of capsaicin) with each meal for 7 days in patients withIBS significantly decreased the rectal pain threshold to anascending series of mechanical distensions (tolerance threshold)[29]. It appears that the development of mechanosensitivity of apopulation of ``silent'' C fibers in response to chemical irritantsis related to changes in the signal transduction mechanism ofperipheral nerve terminals [5].Gender differencesWomen are more likely than men to report IBS symptoms. Inthe U.S. Householder Survey [30], IBS was present in 14.5% ofwomen but in only 7.7% of men. Similarly, in Mexico, in asmall study on subjects aged 17�22 years, IBS was present in29.7% of women and 6.6% of men [31]. Within clinicalpopulations the proportion of women seen ranges from 75 to80%; however, these differences are reversed in India [30,32],which is probably due to differences in access to medical care.Female patients report higher levels of a variety of intestinal andnon-intestinal sensory symptoms despite similar levels of IBSseverity, abdominal pain, psychological symptoms and illnessimpact [33]. In up to 40%, worsening of symptoms is seenduring the menstrual cycle [33], although no differences inplasma estradiol and progesterone levels between women withand without IBS symptoms have been demonstrated. Whilevariations related to menstrual cycle have been shown, thereseems to be no differences in relation to postmenopausal stage.Lower pain thresholds have been reported in female patients, aswell as in animals. Also, gender differences in the centralresponse to visceral pain and anticipation of pain evaluated withbrain PET have been reported in IBS. In contrast to females,male patients during rectal stimulation showed activation of theinsula, a brain region involved in autonomic control andantinociception. Moreover, compared with female patients,male IBS patients appear to have increased sympathetic outflowto heart and skin, differences that were not observed in controlsubjects. Finally, gender differences in therapeutic responses to5-HT3 receptor antagonists are consistent with differences inthe modulation of pain-processing networks by serotoninergicmechanisms [34].Cognitive factorsInappropriate coping styles, illness behavior and inappropriateconcepts about disease, nutrition and medications are commonin IBS patients. These factors may determine the response andability to cope with stressors and may influence healthcareutilization and clinical outcomes.It is generally assumed that patients seen in primary caresettings have less severe symptoms and less psychologicalcompromise than those seen in tertiary referral centers [30].Recruitment by advertisement is extensively used in clinicaltrials. Similarily, the characteristics of IBS patients respondingto such advertisements may differ from those attending aspecialty clinic. In a prospective study surveying 657 IBSpatients � 52% recruited from a functional bowel disordersclinic and 48% from advertisement for clinic trials � the clinicpopulation reported more prevalent and severe abdominal pain,higher psychological symptom scores, higher number of medicalvisits, and lower quality of life [35]. However, when visceralperception studies were conducted, both groups demonstratedevidence of hypersensitivity to rectal distension before and aftersigmoid stimulation, and there were no differences based onrecruitment source [35]. From these results it can be concluded107 IMA J. Vol 3 . February 2001 Brain-Gut Interaction in Irritable Bowel SyndromeMexico�Israel Symposium